相关实验视频
Updated: Jul 4, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
与代谢功能障碍相关的多态性肝病相关的多态性肝病影响到末期肝病的进展
Zehra N Kocas-Kilicarslan1, Zeliha Cetin1, Lanuza A P Faccioli1
1Department of Pathology, Center for Transcriptional Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
PNPLA3,TM6SF2和GCKR的遗传变异影响了从代谢功能障碍相关的脂肪性肝病 (MASLD) 和与酒精有关的肝病 (ALD) 到末期肝病 (ESLD) 的进展. 这些变异的基因定型有助于对早期干预的风险评估.
科学领域:
- 遗传学 是一个遗传学.
- 肝病学 肝病学是一种肝病学.
- 内部医学 内部医学
背景情况:
- 导致肝硬化和末期肝病 (ESLD) 的慢性肝损伤是全球主要的健康负担.
- 虽然已知遗传因素会影响代谢功能障碍相关的脂肪性肝病 (MASLD) 和与酒精有关的肝病 (ALD) 的严重程度,但它们在ESLD发展中的作用尚未得到充分研究.
研究的目的:
- 研究特定遗传多态性对MASLD和ALD向ESLD进展的贡献.
- 确定与肝病进展相关的遗传,人口和临床因素.
主要方法:
- 在健康,MASH,MASLD-ESLD和ALD-ESLD队列中对六种MASLD相关多态的基因定型.
- 多项物流回归分析,以评估遗传和临床因素对疾病进展的综合影响.
主要成果:
- 不同的遗传和临床因素与肝病进展的不同阶段有关.
- PNPLA3 rs738409:G等位基因是ESLD在MASLD和ALD病因方面的重要风险因素.
- TM6SF2 rs58542926:T等位基因与转化为代谢功能障碍相关的脂肪肝炎 (MASH) 的进展有关,而GCKR rs780094:T等位基因与ALD相关的ESLD有关.
结论:
- PNPLA3,TM6SF2和GCKR的小等位基因在与MASLD和ALD相关的ESLD的发展中起着至关重要的作用.
- 在患有MASLD和ALD的患者中,对这些变异的基因分析可以改善风险分层.
- 通过基因检测早期识别高风险个体,可以促进及时干预,防止ESLD.
更多相关视频
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
07:12Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
相关概念视频
Inborn Errors of Metabolism
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Cell Specific Gene Expression
Lysosomal Hydrolases